-
1
-
-
0022555858
-
Platelet-activating factor: A biological active phosphoglyceride
-
Hanahan DJ: Platelet-activating factor: A biological active phosphoglyceride. Annu Rev Biochem 55:483-509, 1986
-
(1986)
Annu Rev Biochem
, vol.55
, pp. 483-509
-
-
Hanahan, D.J.1
-
2
-
-
0027723521
-
PAF molecular heterogeneity: Pathobiological implications
-
McManus LM, Woodard DS, Deavers SI, et al: PAF molecular heterogeneity: Pathobiological implications. Lab Invest 69:639-650, 1993
-
(1993)
Lab Invest
, vol.69
, pp. 639-650
-
-
McManus, L.M.1
Woodard, D.S.2
Deavers, S.I.3
-
3
-
-
0028998204
-
Platelet-activating factor: A mediator for clinicians
-
Imaizumi T, Stafforini DM, Yamada Y, et al: Platelet-activating factor: A mediator for clinicians. J Intern Med 238:5-20, 1995
-
(1995)
J Intern Med
, vol.238
, pp. 5-20
-
-
Imaizumi, T.1
Stafforini, D.M.2
Yamada, Y.3
-
5
-
-
0023278621
-
Human plateletactivating factor acetylhydrolase: Association with lipoprotein particles and role in the degradation of platelet-activating factor
-
Stafforini DM, McIntyre TM, Carter E, et al: Human plateletactivating factor acetylhydrolase: Association with lipoprotein particles and role in the degradation of platelet-activating factor. J Biol Chem 262:4215-4222, 1987
-
(1987)
J Biol Chem
, vol.262
, pp. 4215-4222
-
-
Stafforini, D.M.1
McIntyre, T.M.2
Carter, E.3
-
6
-
-
0023180687
-
Human plasma platelet-activating factor acetylhydrolase: Purification and properties
-
Stafforini DM, Prescott SM, McIntyre TM: Human plasma platelet-activating factor acetylhydrolase: Purification and properties. J Biol Chem 262:4223-4230, 1987
-
(1987)
J Biol Chem
, vol.262
, pp. 4223-4230
-
-
Stafforini, D.M.1
Prescott, S.M.2
McIntyre, T.M.3
-
7
-
-
0024269780
-
Hydrogen peroxide stimulates the synthesis of platelet-activating factor by endothelium and induces endothelial cell-dependent neutrophil adhesion
-
Lewis MS, Whatley RE, Cain P, et al: Hydrogen peroxide stimulates the synthesis of platelet-activating factor by endothelium and induces endothelial cell-dependent neutrophil adhesion. J Clin Invest 82:2045-2055, 1988
-
(1988)
J Clin Invest
, vol.82
, pp. 2045-2055
-
-
Lewis, M.S.1
Whatley, R.E.2
Cain, P.3
-
8
-
-
0025864391
-
3H]acetyl-sn-glycero-3-phosphocholine, a structural analog of plateletactivating factor, by vascular endothelial cells
-
3H]acetyl-sn-glycero-3-phosphocholine, a structural analog of plateletactivating factor, by vascular endothelial cells. Biochem Biophys Res Commun 176:1557-1564, 1991
-
(1991)
Biochem Biophys Res Commun
, vol.176
, pp. 1557-1564
-
-
Mueller, H.W.1
Nollert, M.U.2
Eskin, S.G.3
-
9
-
-
0026032592
-
Platelet-activating factor (PAF) stimulates the production of PAF acetylhydrolase by the human hepatoma cell line, HepG2
-
Satoh K, Imaizumi T, Kawamura Y, et al: Platelet-activating factor (PAF) stimulates the production of PAF acetylhydrolase by the human hepatoma cell line, HepG2. J Clin Invest 87:476-481, 1991
-
(1991)
J Clin Invest
, vol.87
, pp. 476-481
-
-
Satoh, K.1
Imaizumi, T.2
Kawamura, Y.3
-
10
-
-
0030728103
-
Platelet-activating factor (PAF) up-regulates plasma and tissue PAF-acetylhydrolase activity in the rat: Effect of cycloheximide
-
Wang H, Tan X, Qu X, et al: Platelet-activating factor (PAF) up-regulates plasma and tissue PAF-acetylhydrolase activity in the rat: Effect of cycloheximide. Pediatr Res 42:597-603, 1997
-
(1997)
Pediatr Res
, vol.42
, pp. 597-603
-
-
Wang, H.1
Tan, X.2
Qu, X.3
-
11
-
-
0024536159
-
An oxidized derivative of phosphatidylcholine is a substrate for the plateletactivating factor acetylhydrolase from human plasma
-
Stremler KE, Stafforini DM, Prescott SM, et al: An oxidized derivative of phosphatidylcholine is a substrate for the plateletactivating factor acetylhydrolase from human plasma. J Biol Chem 264:5331-5334, 1989
-
(1989)
J Biol Chem
, vol.264
, pp. 5331-5334
-
-
Stremler, K.E.1
Stafforini, D.M.2
Prescott, S.M.3
-
12
-
-
0025908558
-
Human plasma platelet-activating factor acetylhydrolase: Oxidatively fragmented phospholipids as substrates
-
Stremler KE, Stafforini DM, Prescott SM, et al: Human plasma platelet-activating factor acetylhydrolase: Oxidatively fragmented phospholipids as substrates. J Biol Chem 266:11095-11103, 1991
-
(1991)
J Biol Chem
, vol.266
, pp. 11095-11103
-
-
Stremler, K.E.1
Stafforini, D.M.2
Prescott, S.M.3
-
13
-
-
0027027667
-
The platelet-activating factor acetylhydrolase from human plasma prevents oxidative modification of low density lipoprotein
-
Stafforini DM, Zimmerman GA, McIntyre TM, et al: The platelet-activating factor acetylhydrolase from human plasma prevents oxidative modification of low density lipoprotein. Trans Assoc Am Phys 105:44-63, 1992
-
(1992)
Trans Assoc Am Phys
, vol.105
, pp. 44-63
-
-
Stafforini, D.M.1
Zimmerman, G.A.2
McIntyre, T.M.3
-
14
-
-
0027501249
-
Effects of endotoxins and cytokines on the secretion of platelet-activating factor-acetylhydrolase by human decidual macrophages
-
Narahara H, Johnston JM: Effects of endotoxins and cytokines on the secretion of platelet-activating factor-acetylhydrolase by human decidual macrophages. Am J Obstet Gynecol 169:531-537, 1993
-
(1993)
Am J Obstet Gynecol
, vol.169
, pp. 531-537
-
-
Narahara, H.1
Johnston, J.M.2
-
15
-
-
0028968049
-
Anti-inflammatory properties of a platelet-activating factor acetylhydrolase
-
Tjoelker LW, Wilder C, Eberhardt C, et al: Anti-inflammatory properties of a platelet-activating factor acetylhydrolase. Nature 374:549-553, 1995
-
(1995)
Nature
, vol.374
, pp. 549-553
-
-
Tjoelker, L.W.1
Wilder, C.2
Eberhardt, C.3
-
16
-
-
0030786198
-
Cell-specific regulation of expression of plasma-type platelet-activating factor acetylhydrolase in the liver
-
Howard KM, Miller JE, Miwa M, et al: Cell-specific regulation of expression of plasma-type platelet-activating factor acetylhydrolase in the liver. J Biol Chem 272:27543-27548, 1997
-
(1997)
J Biol Chem
, vol.272
, pp. 27543-27548
-
-
Howard, K.M.1
Miller, J.E.2
Miwa, M.3
-
17
-
-
0028859490
-
Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response: Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures
-
Van Lenten BJ, Hama SY, de Beer FC, et al: Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response: Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J Clin Invest 96:2758-2767, 1995
-
(1995)
J Clin Invest
, vol.96
, pp. 2758-2767
-
-
Van Lenten, B.J.1
Hama, S.Y.2
De Beer, F.C.3
-
18
-
-
0032765305
-
In vivo regulation of plasma platelet-activating factor acetylhydrolase activity and mRNA expression during the acute phase response
-
Memon RA, Fuller J, Moser AH, et al: In vivo regulation of plasma platelet-activating factor acetylhydrolase activity and mRNA expression during the acute phase response. Am J Physiol 277(1 pt 2):R94-R103, 1999
-
(1999)
Am J Physiol
, vol.277
, Issue.1 PART 2
-
-
Memon, R.A.1
Fuller, J.2
Moser, A.H.3
-
19
-
-
0029876932
-
Platelet-activating factor levels and PAF acetylhydrolase activities in patients with primary glomerulonephritis
-
Iatrou C, Moustakas G, Antonopoulos S, et al: Platelet-activating factor levels and PAF acetylhydrolase activities in patients with primary glomerulonephritis. Nephron 72:611-616, 1996
-
(1996)
Nephron
, vol.72
, pp. 611-616
-
-
Iatrou, C.1
Moustakas, G.2
Antonopoulos, S.3
-
20
-
-
0026802165
-
Paf-acether acetylhydrolase activity is increased in patients with rheumatic diseases
-
Dulioust A, Hilliquin P, Menkes CJ, et al: Paf-acether acetylhydrolase activity is increased in patients with rheumatic diseases. Scand J Rheumatol 21:161-164, 1992
-
(1992)
Scand J Rheumatol
, vol.21
, pp. 161-164
-
-
Dulioust, A.1
Hilliquin, P.2
Menkes, C.J.3
-
21
-
-
0028029156
-
Plasma degradation of platelet-activating factor in severely ill patients with clinical sepsis
-
Graham RM, Stephens CJ, Silvester W, et al: Plasma degradation of platelet-activating factor in severely ill patients with clinical sepsis. Crit Care Med 22:204-212, 1994
-
(1994)
Crit Care Med
, vol.22
, pp. 204-212
-
-
Graham, R.M.1
Stephens, C.J.2
Silvester, W.3
-
22
-
-
0028178445
-
Platelet-activating factor (PAF) acetylhydrolase activity, type II phospholipase A2, and cytokine levels in patients with sepsis
-
Endo S, Inada K, Yamashita H, et al: Platelet-activating factor (PAF) acetylhydrolase activity, type II phospholipase A2, and cytokine levels in patients with sepsis. Res Commun Mol Pathol Pharmacol 83:289-295, 1994
-
(1994)
Res Commun Mol Pathol Pharmacol
, vol.83
, pp. 289-295
-
-
Endo, S.1
Inada, K.2
Yamashita, H.3
-
23
-
-
0024205844
-
The degradation of platelet-activating factor in serum and its discriminative value in atherosclerotic patients
-
Ostermann G, Lang A, Holtz H, et al: The degradation of platelet-activating factor in serum and its discriminative value in atherosclerotic patients. Thromb Res 52:529-540, 1988
-
(1988)
Thromb Res
, vol.52
, pp. 529-540
-
-
Ostermann, G.1
Lang, A.2
Holtz, H.3
-
24
-
-
0023251376
-
Plasma from atherosclerotic patients exerts an increased degradation of plateletactivating factor
-
Ostermann G, Ruhling K, Zabel-Langhennig R, et al: Plasma from atherosclerotic patients exerts an increased degradation of plateletactivating factor. Thromb Res 47:279-285, 1987
-
(1987)
Thromb Res
, vol.47
, pp. 279-285
-
-
Ostermann, G.1
Ruhling, K.2
Zabel-Langhennig, R.3
-
25
-
-
0026751255
-
Platelet-activating factor acetylhydrolase in plasma lipoproteins from patients with ischemic stroke
-
Satoh K, Yoshida H, Imaizumi T, et al: Platelet-activating factor acetylhydrolase in plasma lipoproteins from patients with ischemic stroke. Stroke 23:1090-1092, 1992
-
(1992)
Stroke
, vol.23
, pp. 1090-1092
-
-
Satoh, K.1
Yoshida, H.2
Imaizumi, T.3
-
26
-
-
0024357049
-
Increased activity of the platelet-activating factor acetylhydrolase in plasma low density lipoprotein from patients with essential hypertension
-
Satoh K, Imiazumi T, Kawamura Y, et al: Increased activity of the platelet-activating factor acetylhydrolase in plasma low density lipoprotein from patients with essential hypertension. Prostaglandins 37:673-682, 1989
-
(1989)
Prostaglandins
, vol.37
, pp. 673-682
-
-
Satoh, K.1
Imiazumi, T.2
Kawamura, Y.3
-
27
-
-
0030822866
-
Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolemia
-
Karabina SAP, Elisaf M, Bairaktari E, et al: Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolemia. Eur J Clin Invest 27:595-602, 1997
-
(1997)
Eur J Clin Invest
, vol.27
, pp. 595-602
-
-
Karabina, S.A.P.1
Elisaf, M.2
Bairaktari, E.3
-
28
-
-
0030699106
-
Determinants of plasma platelet-activating factor acetylhydrolase: Heritability and relationship to plasma lipoproteins
-
Guerra R, Zhao B, Mooser V, et al: Determinants of plasma platelet-activating factor acetylhydrolase: Heritability and relationship to plasma lipoproteins. J Lipid Res 38:2281-2288, 1997
-
(1997)
J Lipid Res
, vol.38
, pp. 2281-2288
-
-
Guerra, R.1
Zhao, B.2
Mooser, V.3
-
29
-
-
0024855170
-
Blood platelet behaviour in patients with a type 1 diabetes mellitus
-
Spangenberg P, Schymik CH, Hofmann B, et al: Blood platelet behaviour in patients with a type 1 diabetes mellitus. Exp Clin Endocrinol 94:329-337, 1989
-
(1989)
Exp Clin Endocrinol
, vol.94
, pp. 329-337
-
-
Spangenberg, P.1
Schymik, C.H.2
Hofmann, B.3
-
30
-
-
0024600767
-
Enhanced degradation of platelet-activating factor in serum from diabetic patients
-
Hofmann B, Ruhling K, Spangenberg P, et al: Enhanced degradation of platelet-activating factor in serum from diabetic patients. Haemostasis 19:180-184, 1989
-
(1989)
Haemostasis
, vol.19
, pp. 180-184
-
-
Hofmann, B.1
Ruhling, K.2
Spangenberg, P.3
-
31
-
-
0025293212
-
Activity of plateletactivating factor (PAF) acetylhydrolase in plasma from healthy habitual cigarette smokers
-
Imaizumi T, Satoh K, Yoshida H, et al: Activity of plateletactivating factor (PAF) acetylhydrolase in plasma from healthy habitual cigarette smokers. Heart Vessels 5:81-86, 1990
-
(1990)
Heart Vessels
, vol.5
, pp. 81-86
-
-
Imaizumi, T.1
Satoh, K.2
Yoshida, H.3
-
32
-
-
0024497306
-
Hypertriglyceridemia in the acquired immunodeficiency syndrome
-
Grunfeld C, Kotler DP, Hamadeh R, et al: Hypertriglyceridemia in the acquired immunodeficiency syndrome. Am J Med 86:27-31, 1989
-
(1989)
Am J Med
, vol.86
, pp. 27-31
-
-
Grunfeld, C.1
Kotler, D.P.2
Hamadeh, R.3
-
33
-
-
0026716993
-
Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome
-
Grunfeld C, Pang M, Doerrler W, et al: Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. J Clin Endocrinol Metab 74:1045-1052, 1992
-
(1992)
J Clin Endocrinol Metab
, vol.74
, pp. 1045-1052
-
-
Grunfeld, C.1
Pang, M.2
Doerrler, W.3
-
34
-
-
0027167664
-
The hypertriglyceridemia of acquired immunodeficiency syndrome is associated with an increased prevalence of low density lipoprotein subclass pattern B
-
Feingold KR, Krauss RM, Pang M, et al: The hypertriglyceridemia of acquired immunodeficiency syndrome is associated with an increased prevalence of low density lipoprotein subclass pattern B. J Clin Endocrinol Metab 76:1423-1427, 1993
-
(1993)
J Clin Endocrinol Metab
, vol.76
, pp. 1423-1427
-
-
Feingold, K.R.1
Krauss, R.M.2
Pang, M.3
-
35
-
-
0027122957
-
1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS among Adolescents and Adults
-
Centers for Disease Control and Prevention: 1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults. MMWR 41(No.RR-17):1-13, 1992
-
(1992)
MMWR
, vol.41
, Issue.RR-17
, pp. 1-13
-
-
-
36
-
-
0009715676
-
Evidence of unique metabolic effects of protease inhibitors
-
Alexandria, VA, Westover Management Group, abstr 157
-
Mulligan K, Tai VW, Algren H, et al: Evidence of unique metabolic effects of protease inhibitors. Fifth Annual Conference on Retroviruses and Opportunistic Infections. Alexandria, VA, Westover Management Group, 1998 (abstr 157)
-
(1998)
Fifth Annual Conference on Retroviruses and Opportunistic Infections
-
-
Mulligan, K.1
Tai, V.W.2
Algren, H.3
-
38
-
-
0015348189
-
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifugation
-
Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifugation. Clin Chem 18:499-502, 1972
-
(1972)
Clin Chem
, vol.18
, pp. 499-502
-
-
Friedewald, W.T.1
Levy, R.I.2
Fredrickson, D.S.3
-
39
-
-
0030729662
-
Evaluation and clinical application of a direct low-density lipoprotein cholesterol assay in normolipidemic and hyperlipidemic adults
-
Yu HH, Ginsburg GS, Harris N, et al: Evaluation and clinical application of a direct low-density lipoprotein cholesterol assay in normolipidemic and hyperlipidemic adults. Am J Cardiol 80:1295-1299, 1997
-
(1997)
Am J Cardiol
, vol.80
, pp. 1295-1299
-
-
Yu, H.H.1
Ginsburg, G.S.2
Harris, N.3
-
40
-
-
0025872834
-
Circulating interferon-α levels and hypertriglyceridemia in the acquired immunodeficiency syndrome
-
Grunfeld C, Kotler DP, Shigenaga JK, et al: Circulating interferon-α levels and hypertriglyceridemia in the acquired immunodeficiency syndrome. Am J Med 90:154-162, 1991
-
(1991)
Am J Med
, vol.90
, pp. 154-162
-
-
Grunfeld, C.1
Kotler, D.P.2
Shigenaga, J.K.3
-
41
-
-
0025101682
-
Genetic heterogeneity of lipoproteins in inbred strains of mice: Analysis by gel-permeation chromatography
-
Jiao S, Cole TG, Kitchens RT, et al: Genetic heterogeneity of lipoproteins in inbred strains of mice: Analysis by gel-permeation chromatography. Metabolism 39:155-160, 1990
-
(1990)
Metabolism
, vol.39
, pp. 155-160
-
-
Jiao, S.1
Cole, T.G.2
Kitchens, R.T.3
-
42
-
-
0028225106
-
Plateletactivating factor: A candidate human immunodeficiency virus type 1-induced neurotoxin
-
Gelbard HA, Nottet HSLM, Swindells S, et al: Plateletactivating factor: A candidate human immunodeficiency virus type 1-induced neurotoxin. J Virol 68:4628-4635, 1994
-
(1994)
J Virol
, vol.68
, pp. 4628-4635
-
-
Gelbard, H.A.1
Nottet, H.S.L.M.2
Swindells, S.3
-
43
-
-
0032512846
-
Expression of plasma platelet-activating factor acetylhydrolase is transcriptionally regulated by mediators of inflammation
-
Cao Y, Stafforini DM, Zimmerman GA, et al: Expression of plasma platelet-activating factor acetylhydrolase is transcriptionally regulated by mediators of inflammation. J Biol Chem 273:4012-4020, 1998
-
(1998)
J Biol Chem
, vol.273
, pp. 4012-4020
-
-
Cao, Y.1
Stafforini, D.M.2
Zimmerman, G.A.3
-
44
-
-
0024384377
-
Multiple cytokines stimulate hepatic lipid synthesis in vivo
-
Feingold KR, Soued M, Serio MK, et al: Multiple cytokines stimulate hepatic lipid synthesis in vivo. Endocrinology 125:267-274, 1989
-
(1989)
Endocrinology
, vol.125
, pp. 267-274
-
-
Feingold, K.R.1
Soued, M.2
Serio, M.K.3
-
45
-
-
0030902788
-
Interferon alpha induces disorder of lipid metabolism by lowering postheparin lipases and cholesteryl ester transfer protein activities in patients with chronic hepatitis C
-
Shinohara E, Yamashita S, Kihara S, et al: Interferon alpha induces disorder of lipid metabolism by lowering postheparin lipases and cholesteryl ester transfer protein activities in patients with chronic hepatitis C. Hepatology 25:1502-1506, 1997
-
(1997)
Hepatology
, vol.25
, pp. 1502-1506
-
-
Shinohara, E.1
Yamashita, S.2
Kihara, S.3
-
46
-
-
0024603895
-
Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity
-
Steinberg D, Parthasarathy S, Carew TE, et al: Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320:915-924, 1989
-
(1989)
N Engl J Med
, vol.320
, pp. 915-924
-
-
Steinberg, D.1
Parthasarathy, S.2
Carew, T.E.3
-
47
-
-
0024439446
-
Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man
-
Yla-Herttuala S, Palinski W, Rosenfeld ME, et al: Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 84:1086-1095, 1989
-
(1989)
J Clin Invest
, vol.84
, pp. 1086-1095
-
-
Yla-Herttuala, S.1
Palinski, W.2
Rosenfeld, M.E.3
-
48
-
-
0024521694
-
Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by platelet-activating factor acetylhydrolase
-
Steinbrecher UP, Pritchard PH: Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by platelet-activating factor acetylhydrolase. J Lipid Res 30:305-315, 1989
-
(1989)
J Lipid Res
, vol.30
, pp. 305-315
-
-
Steinbrecher, U.P.1
Pritchard, P.H.2
-
49
-
-
0001096583
-
Lysophosphatidylcholine: A chemotactic factor for human monocytes and its potential role in atherogenesis
-
Quinn MT, Parthasarathy S, Steinberg D: Lysophosphatidylcholine: A chemotactic factor for human monocytes and its potential role in atherogenesis. Proc Natl Acad Sci USA 85:2805-2809, 1988
-
(1988)
Proc Natl Acad Sci USA
, vol.85
, pp. 2805-2809
-
-
Quinn, M.T.1
Parthasarathy, S.2
Steinberg, D.3
-
50
-
-
0025286558
-
Impairment of endothelial-dependent arterial relaxation by lysolecithin in modified low density lipoproteins
-
Kugiyama K, Kerns SA, Morrisett JD, et al: Impairment of endothelial-dependent arterial relaxation by lysolecithin in modified low density lipoproteins. Nature 344:160-162, 1990
-
(1990)
Nature
, vol.344
, pp. 160-162
-
-
Kugiyama, K.1
Kerns, S.A.2
Morrisett, J.D.3
-
51
-
-
0028079980
-
Lysophosphatidylcholine plays an essential role in the mitogenic effects of oxidized low density lipoproteins in murine macrophages
-
Sakai M, Miyazaki A, Hakamata H, et al: Lysophosphatidylcholine plays an essential role in the mitogenic effects of oxidized low density lipoproteins in murine macrophages. J Biol Chem 269:31430-31435, 1994
-
(1994)
J Biol Chem
, vol.269
, pp. 31430-31435
-
-
Sakai, M.1
Miyazaki, A.2
Hakamata, H.3
|